Patients' perspectives on taking warfarin: Qualitative study in family practice

被引:73
作者
Dantas G.C. [1 ]
Thompson B.V. [2 ]
Manson J.A. [2 ]
Tracy C.S. [1 ]
Upshur R.E.G. [1 ,2 ,3 ]
机构
[1] Primary Care Research Unit, S./Women's Coll. Hlth. Sci. Centre, Toronto, Ont. M4N 3M5
[2] Dept. of Fam. and Community Medicine, S./Women's Coll. Hlth. Sci. Centre, Toronto, Ont. M4N 3M5
[3] Department of Public Health Sciences, University of Toronto, McMurrich Building, Toronto, Ont. M5S 1A8
关键词
Anticoagulation; Family Practice; Patient Preference; Primary Care; Qualitative Research;
D O I
10.1186/1471-2296-5-15
中图分类号
学科分类号
摘要
Background: Despite the well-documented benefits of using warfarin to prevent stroke, physicians remain reluctant to initiate therapy, and especially so with the elderly owing to the higher risk of hemorrhage. Prior research suggests that patients are more accepting of the risk of bleeding than are physicians, although there have been few qualitative studies. The aim of this study was to employ qualitative methods to investigate the experience and perspective of individuals taking warfarin. Methods: We conducted face-to-face interviews with 21 older patients (12 male, 9 female) who had been taking warfarin for a minimum of six months. Participants were patients at a family practice clinic situated in a large, tertiary care teaching hospital. We used a semistructured interview guide with four main thematic areas: decision-making, knowledge/education, impact, and satisfaction. Data were analysed according to the principles of content analysis. Results and Discussion: Participants tended to have minimal input into the decision to initiate warfarin therapy, instead relying in great part on physicians' expertise. There appeared to be low retention of information received regarding the therapy; half the patients in our sample possessed only a superficial level of understanding of the risks and benefits. This notwithstanding, participants reported a high level of satisfaction with the care provided and a low level of impact on their day-to-day lives. Conclusions: Minimal patient involvement in the initial decision and modest knowledge did not appear to diminish satisfaction with warfarin management. At the same time, care providers exert a tremendous influence on the initiation of warfarin therapy and should strive to incorporate patient preferences and expectations into the decision-making process.
引用
收藏
页码:1 / 9
页数:8
相关论文
共 25 条
[1]
Go A., Hylek E., Phillips K., Chang Y., Henault L., Selby J., Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk factors in Atrial fibrillation (ATRIA) Study, JAMA, 285, pp. 2370-2375, (2001)
[2]
Petersen P., Boysen G., Godfredsen J., Andersen E., Andersen B., Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK Study, Lancet, 177, pp. 175-179, (1989)
[3]
Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke, Lancet, 342, pp. 1255-1262, (1993)
[4]
Hirsh J., Dalen J., Guyatt G., The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis, Chest, 119, (2001)
[5]
Ridker P., Goldhaber S., Danielson E., Rosenberg Y., Eby C., Deitcher S., Cushman M., Moll S., Kessler C., Elliott C., Paulson R., Wong T., Bauer K., Schwartz B., Miletich J., Bounameaux H., Glynn R., Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism, N Engl J Med, 348, pp. 1425-1434, (2003)
[6]
Bungard T., Ghali W., McAlister F., Buchan A., Cave A., Hamilton P., Mitchell L., Shuaib A., Teo K., Tsuyuki R., The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation, Can J Cardiol, 19, pp. 280-284, (2003)
[7]
Bungard T., Ghali W., Teo K., McAlister F., Tsuyuki R., Why do patients with atrial fibrillation not receive warfarin?, Arch Int Med, 160, pp. 41-46, (2000)
[8]
Hart R., Anticoagulation therapy for patients with atrial fibrillation, CMAJ, 163, pp. 956-957, (2000)
[9]
Devereaux P., Anderson D., Gardner M., Putnam W., Flowerdew G., Brownell B., Nagpal S., Cox J., Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: Observational study, BMJ, 323, pp. 1218-1222, (2001)
[10]
Howitt A., Armstrong D., Implementing evidence based medicine in general practice: Audit and qualitative study of anti-thrombotic treatment for atrial fibrillation, BMJ, 318, pp. 1324-1327, (1999)